Drug Developement/Delivery
- 2024 FDA Approvals: 50 New Drugs
- Diabetes & Weight Loss Drug Tirzepatide Now Approved for OSA (Obstructive Sleep Apnea)
- Small Nucleic Acid Drugs Expected to Be Approved by 2025
- Nucleic Acid Therapeutics: Approvals and Potential Blockbusters
- FDA Approved First HER2/HER3 Bispecific Antibody - Zenocutuzumab (Bizengri)
- Bispecific Antibodies - Current Status and Prospects
- Targeted Therapies for Systemic Lupus Erythematosus (SLE)
- Positive Trial Results of Semaglutide for MASH
- Claudin 18.2: A Promising New Target for Breakthrough Cancer Treatments
- Anticipating FDA Approval: Three Game-Changing Drugs in Q4 2024